BioInvest

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

  NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

 May 08, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant    World Hepatitis Allianc...

 April 16, 2024 | News

D3 Bio Secures $62M in Series A+ Financing for Cancer Drug Development

 D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs announces its cl...

 April 09, 2024 | News

Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) announced  it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...

 March 08, 2024 | News

Merck Opens new € 20 Million Distribution Center in Brazil

New site in Cajamar, São Paulo has 2.5 times more storage capacity than previous space in Cotia, São Paulo 13,000 square-meters space for ...

 March 04, 2024 | News

Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million

     Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...

 February 26, 2024 | News

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

  BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

 February 14, 2024 | News

BioNTech's $200 Million Investment in Autolus Marks Milestone in Strategic CAR-T Collaboration, Revolutionizing Cancer Therapy

      Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both...

 February 08, 2024 | News

Novo Nordisk's Investment Arm, Novo Holdings, Seals $16.5 Billion Deal to Acquire Catalent in All-Cash Transaction

Catalent, Inc. (NYSE: CTLT), a prominent player in advancing global patient treatment solutions, and Novo Holdings, a holding and investment entity oversee...

 February 06, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

 February 01, 2024 | News

Singapore's GDMC Raises $21M to Boost Global Genetic Therapy Manufacturing

Funding is led by existing investor Celadon Partners with participation from SEEDS Capital, NSG Ventures and WI Harper Group GDMC aims to use the ...

 January 26, 2024 | News

PRISM BioLab Secures 1.5 Billion Yen in Series C Funding for Advancing Protein-Protein Interaction Technologies

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

 January 25, 2024 | News

Vaxart Gets $9.27M BARDA Award for Phase 2b COVID-19 Oral Pill Study

“We are very honored to receive this BARDA award, which will support the innovative approach of our oral pill vaccine platform,” said Dr. Micha...

 January 22, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close